Table 2.
Relationship between MEG3 methylation in plasma and clinical pathological characteristics.
Clinical pathological characteristics | Methylation | P | R | ORa (95% CI) | ||
---|---|---|---|---|---|---|
M | MU, U | |||||
Lymph nodes metastasis | Positive | 52 | 12 | <0.001 | 0.435 | 7.526 (3.577–15.835) |
Negative | 38 | 66 | ||||
HPV infection | Positive | 82 | 48 | <0.001 | 0.353 | 6.406 (2.718–15.099) |
Negative | 8 | 30 | ||||
Tumor size | ≥4 cm | 46 | 30 | 0.100 | ||
<4 cm | 44 | 48 | ||||
Differentiation | Poorly | 34 | 30 | 0.927 | ||
Well and Moderately | 56 | 48 | ||||
Depth of invasion | >2/3 | 52 | 36 | 0.132 | ||
≤2/3 | 28 | 42 | ||||
LVSI | Positive | 50 | 34 | 0.122 | ||
Negative | 40 | 44 | ||||
Age | >50 | 42 | 40 | 0.551 | ||
≤50 | 48 | 38 | ||||
Menopause | Yes | 30 | 36 | 0.090 | ||
No | 60 | 42 | ||||
Histology | Squamous | 76 | 60 | 0.216 | ||
Adenocarci-noma | 14 | 18 |
aOR (Odds ratio).